Genomic Vision Société Anonyme at it's ordinary general meeting held on July 11, 2022 approved the resolutions included: the revocation of Mrs. Remy-Renou's mandate as Chair of the Executive Board and the appointment of a new member of the Executive Board, Mrs. Emilie Chataignier; the revocation of the mandates of all the members of the Supervisory Board – Mrs. Elisabeth Ourliac, Mrs. Tammou Abikhzer and Mr. Stéphane Verdood – and the appointment of Mrs. Florence Alouch, Mr. Mohammed Afshar and Mr. Eric Edery for a 6-year term as provided for in the Company's articles of association. The reconstituted Supervisory Board met following the ordinary general meeting and decided to appoint Mrs. Florence Alouch as Chair of the Supervisory Board and Mr. Aaron Bensimon as Chair of the Executive Board. The objective of these changes in Genomic Vision's governance is to strengthen the Company's commercial momentum.